Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants

Author:

Wang Chumeng,Ramasamy Akshara,Verduzco-Gutierrez Monica,Brode W. Michael,Melamed Esther

Abstract

AbstractSARS-CoV-2 infection leading to Coronavirus Disease 2019 (COVID-19) has caused more than 762 million infections worldwide, with 10–30% of patients suffering from post-acute sequelae of SARS-CoV-2 infections (PASC). Initially thought to primarily affect the respiratory system, it is now known that SARS-CoV-2 infection and PASC can cause dysfunction in multiple organs, both during the acute and chronic stages of infection. There are also multiple risk factors that may predispose patients to worse outcomes from acute SARS-CoV-2 infection and contribute to PASC, including genetics, sex differences, age, reactivation of chronic viruses such as Epstein Barr Virus (EBV), gut microbiome dysbiosis, and behavioral and lifestyle factors, including patients’ diet, alcohol use, smoking, exercise, and sleep patterns. In addition, there are important social determinants of health, such as race and ethnicity, barriers to health equity, differential cultural perspectives and biases that influence patients’ access to health services and disease outcomes from acute COVID-19 and PASC. Here, we review risk factors in acute SARS-CoV-2 infection and PASC and highlight social determinants of health and their impact on patients affected with acute and chronic sequelae of COVID-19.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Reference108 articles.

1. WHO Coronavirus (COVID-19.) Dashboard [Internet]. [cited 2023 Apr 9]. Available from: https://covid19.who.int.

2. CDC. COVID-19 and Your Health [Internet]. Cent. Dis. Control Prev. 2020 [cited 2022 Aug 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/asthma.html.

3. A clinical case definition of post COVID-19. condition by a Delphi consensus, 6 October 2021 [Internet]. [cited 2022 Aug 4]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.

4. CDC, Post. -COVID Conditions [Internet]. Cent. Dis. Control Prev. 2022 [cited 2022 Aug 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.

5. Choo SY. The HLA System: Genetics, Immunology, Clinical Testing, and clinical implications. Yonsei Med J. 2007;48:11–23.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3